Condition: Ischemic Stroke · Sponsor: Ludwig-Maximilians - University of Munich
The primary aim of the study is to derive and validate risk scores for vascular endpoints (recurrent stroke, myocardial infarction, and other complications of stroke) and for death following an incident stroke. For this purpose patients with an incident stroke will be followed for 36 months with additional assessments at 3, 12, 24 and 36 months.
This description comes directly from the study's public registry record.
Martin Dichgans, Prof. · +49 (0)89 4400 · martin.dichgans@med.uni-muenchen.de
Always discuss trial participation with your own doctor first.
| Center for Stroke Research Berlin, Charité Universitätsmedizin Berlin | Berlin, Germany | Active Not Recruiting |
| Interdisciplinary Stroke Center Munich, Klinikum der Universität München | Munich, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01364168